Surgical approach for early breast cancer with few lymph node concerns

This trial is studying a surgical strategy for patients with early-stage breast cancer (hormone-responsive, HER2-negative) who have only 1 or 2 suspicious lymph nodes. Instead of removing all the underarm lymph nodes as traditionally done, doctors are using a more targeted approach to remove only the affected nodes, potentially sparing patients from the side effects of more extensive surgery.

Traditional breast cancer surgery removes many underarm lymph nodes, which can cause long-term side effects like arm swelling and numbness. This study is exploring whether a gentler, more targeted surgical approach is safe and effective for patients with very limited lymph node involvement.